"This is the peer reviewed version of the following article: [Ann Noninvasive Electrocardiol 2017;22(1):e12378, DOI: 10.1111/anec.12378], which has been published in final form at [http://onlinelibrary.wiley.com/doi/10.1111/anec.12378/pdf]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving."

Despite the strong evidence of the clinical utility of QTc prolongation as a surrogate marker of cardiac risk, QTc measurement is not part of clinical routine either in hospital or in physician of fi ces. We evaluated a novel device ( “the QT scale”) to measure heart rate (HR) and QTc interval.

Peer Reviewed